Chen Li

发表

A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis

Pei-hua Lu, Min-Bin Chen, Zhi-yang Jiang, 2011, Breast Cancer Research and Treatment.

P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer

W. Shen, Pei-hua Lu, Xiao-yang Wu, 2012, PloS one.

Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects

Jie Yang, W. Shen, Pei-hua Lu, 2011, Breast Cancer Research and Treatment.

The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent

F. Liu, Chao-ying Liu, Pei-hua Lu, 2015, Cancer biology & therapy.

No significant association results obtained from significant association evidence: the ongoing uncertainty of TP53 codon 72 polymorphism and breast cancer risk

Pei-hua Lu, Guo-qing Tao, Mu-xin Wei, 2010, Breast Cancer Research and Treatment.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls

W. Shen, Pei-hua Lu, Yu-jiang Guo, 2011, Molecular Biology Reports.

MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.

W. Shen, Junyi Han, Pei-hua Lu, 2014, Cellular signalling.

Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects

W. Shen, Pei-hua Lu, Xiao-yang Wu, 2011, Breast Cancer Research and Treatment.

Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk

W. Shen, Tong Wang, Pei-hua Lu, 2010, Breast Cancer Research and Treatment.

Unincluded subjects need to be included for concerning the real association between TNFa-308 G/A polymorphism and cancer susceptibility

Pei-hua Lu, Wenxiang Shen, Chen Li, 2011, Breast Cancer Research and Treatment.

Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk

Pei-hua Lu, Mu-xin Wei, Xiao Liu, 2010, Breast Cancer Research and Treatment.

New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk

W. Shen, Pei-hua Lu, Mingyue Wu, 2011, Breast Cancer Research and Treatment.